These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 36662868)

  • 1. Cullin-5 deficiency orchestrates the tumor microenvironment to promote mammary tumor development through CREB1-CCL2 signaling.
    Chen S; Shao F; Zeng J; Guo S; Wang L; Sun H; Lei JH; Lyu X; Gao S; Chen Q; Miao K; Xu X; Deng CX
    Sci Adv; 2023 Jan; 9(3):eabq1395. PubMed ID: 36662868
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cullin3 deficiency shapes tumor microenvironment and promotes cholangiocarcinoma in liver-specific Smad4/Pten mutant mice.
    Zhao M; Quan Y; Zeng J; Lyu X; Wang H; Lei JH; Feng Y; Xu J; Chen Q; Sun H; Xu X; Lu L; Deng CX
    Int J Biol Sci; 2021; 17(15):4176-4191. PubMed ID: 34803491
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The cAMP responsive element binding protein 1 transactivates epithelial membrane protein 2, a potential tumor suppressor in the urinary bladder urothelial carcinoma.
    Li CF; Wu WJ; Wu WR; Liao YJ; Chen LR; Huang CN; Li CC; Li WM; Huang HY; Chen YL; Liang SS; Chow NH; Shiue YL
    Oncotarget; 2015 Apr; 6(11):9220-39. PubMed ID: 25940704
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dissecting the heterogeneity and tumorigenesis of BRCA1 deficient mammary tumors via single cell RNA sequencing.
    Sun H; Zeng J; Miao Z; Lei KC; Huang C; Hu L; Su SM; Chan UI; Miao K; Zhang X; Zhang A; Guo S; Chen S; Meng Y; Deng M; Hao W; Lei H; Lin Y; Yang Z; Tang D; Wong KH; Zhang XD; Xu X; Deng CX
    Theranostics; 2021; 11(20):9967-9987. PubMed ID: 34815798
    [No Abstract]   [Full Text] [Related]  

  • 5. A mammary-specific, long-range deletion on mouse chromosome 11 accelerates Brca1-associated mammary tumorigenesis.
    Triplett AA; Montagna C; Wagner KU
    Neoplasia; 2008 Dec; 10(12):1325-34. PubMed ID: 19048111
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of TGF-β signaling in generation of CD39+CD73+ myeloid cells in tumors.
    Ryzhov SV; Pickup MW; Chytil A; Gorska AE; Zhang Q; Owens P; Feoktistov I; Moses HL; Novitskiy SV
    J Immunol; 2014 Sep; 193(6):3155-64. PubMed ID: 25127858
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Loss of function of BRCA1 promotes EMT in mammary tumors through activation of TGFβR2 signaling pathway.
    Bai F; Wang C; Liu X; Hollern D; Liu S; Fan C; Liu C; Ren S; Herschkowitz JI; Zhu WG; Pei XH
    Cell Death Dis; 2022 Mar; 13(3):195. PubMed ID: 35236825
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Caveolin-1 and accelerated host aging in the breast tumor microenvironment: chemoprevention with rapamycin, an mTOR inhibitor and anti-aging drug.
    Mercier I; Camacho J; Titchen K; Gonzales DM; Quann K; Bryant KG; Molchansky A; Milliman JN; Whitaker-Menezes D; Sotgia F; Jasmin JF; Schwarting R; Pestell RG; Blagosklonny MV; Lisanti MP
    Am J Pathol; 2012 Jul; 181(1):278-93. PubMed ID: 22698676
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Post‑translational modification of CREB‑1 decreases collagen I expression by inhibiting the TGF‑β1 signaling pathway in rat hepatic stellate cells.
    Deng X; Deng L; Wang P; Cheng C; Xu K
    Mol Med Rep; 2016 Dec; 14(6):5751-5759. PubMed ID: 27840939
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multiple genetic changes are associated with mammary tumorigenesis in Brca1 conditional knockout mice.
    Brodie SG; Xu X; Qiao W; Li WM; Cao L; Deng CX
    Oncogene; 2001 Nov; 20(51):7514-23. PubMed ID: 11709723
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PDGFRβ is an essential therapeutic target for BRCA1-deficient mammary tumors.
    Bai F; Liu S; Liu X; Hollern DP; Scott A; Wang C; Zhang L; Fan C; Fu L; Perou CM; Zhu WG; Pei XH
    Breast Cancer Res; 2021 Jan; 23(1):10. PubMed ID: 33478572
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genome-wide CRISPR/Cas9 knockout screening uncovers a novel inflammatory pathway critical for resistance to arginine-deprivation therapy.
    Chu CY; Lee YC; Hsieh CH; Yeh CT; Chao TY; Chen PH; Lin IH; Hsieh TH; Shih JW; Cheng CH; Chang CC; Lin PS; Huang YL; Chen TM; Yen Y; Ann DK; Kung HJ
    Theranostics; 2021; 11(8):3624-3641. PubMed ID: 33664852
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overexpression of XIST facilitates cell proliferation, invasion and suppresses cell apoptosis by reducing radio-sensitivity of glioma cells via miR-329-3p/CREB1 axis.
    Wang YP; Li HQ; Chen JX; Kong FG; Mo ZH; Wang JZ; Huang KM; Li XN; Yan Y
    Eur Rev Med Pharmacol Sci; 2020 Mar; 24(6):3190-3203. PubMed ID: 32271437
    [TBL] [Abstract][Full Text] [Related]  

  • 14. BRCA1 suppresses epithelial-to-mesenchymal transition and stem cell dedifferentiation during mammary and tumor development.
    Bai F; Chan HL; Scott A; Smith MD; Fan C; Herschkowitz JI; Perou CM; Livingstone AS; Robbins DJ; Capobianco AJ; Pei XH
    Cancer Res; 2014 Nov; 74(21):6161-72. PubMed ID: 25239453
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lack of ABCG2 shortens latency of BRCA1-deficient mammary tumors and this is not affected by genistein or resveratrol.
    Zander SA; Kersbergen A; Sol W; Gonggrijp M; van de Wetering K; Jonkers J; Borst P; Rottenberg S
    Cancer Prev Res (Phila); 2012 Aug; 5(8):1053-60. PubMed ID: 22767648
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The CUL4B/AKT/β-Catenin Axis Restricts the Accumulation of Myeloid-Derived Suppressor Cells to Prohibit the Establishment of a Tumor-Permissive Microenvironment.
    Qian Y; Yuan J; Hu H; Yang Q; Li J; Zhang S; Jiang B; Shao C; Gong Y
    Cancer Res; 2015 Dec; 75(23):5070-83. PubMed ID: 26450912
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Contributions of the RhoA guanine nucleotide exchange factor Net1 to polyoma middle T antigen-mediated mammary gland tumorigenesis and metastasis.
    Zuo Y; Ulu A; Chang JT; Frost JA
    Breast Cancer Res; 2018 May; 20(1):41. PubMed ID: 29769144
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Upregulation of IL-6 in CUL4B-deficient myeloid-derived suppressive cells increases the aggressiveness of cancer cells.
    Xu Z; Li L; Qian Y; Song Y; Qin L; Duan Y; Wang M; Li P; Jiang B; Ma C; Shao C; Gong Y
    Oncogene; 2019 Jul; 38(30):5860-5872. PubMed ID: 31235785
    [TBL] [Abstract][Full Text] [Related]  

  • 19. cAMP response element binding protein1 is essential for activation of steroyl co-enzyme a desaturase 1 (Scd1) in mouse lung type II epithelial cells.
    Antony N; Weir JR; McDougall AR; Mantamadiotis T; Meikle PJ; Cole TJ; Bird AD
    PLoS One; 2013; 8(4):e59763. PubMed ID: 23637738
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Disruption of bone morphogenetic protein receptor 2 (BMPR2) in mammary tumors promotes metastases through cell autonomous and paracrine mediators.
    Owens P; Pickup MW; Novitskiy SV; Chytil A; Gorska AE; Aakre ME; West J; Moses HL
    Proc Natl Acad Sci U S A; 2012 Feb; 109(8):2814-9. PubMed ID: 21576484
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.